Preview

Planning And Strategy Case Study

Powerful Essays
Open Document
Open Document
1499 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Planning And Strategy Case Study
If we discuss the problem number one that explain Merck has found 2 kind of statins and they are successfull in market, we can talk solution about marketing and the concept of planning and strategy. At the time particularly Mevacor and Zocor hit the market, Lipitor just syinthesized by Warner-Lambert and it was still done animal testing or in the other words Lipitor is still developed become great statin in the world. To give alternative solution for the problem number one, Lipitor should understand about concept of planning and strategy and arrange suitable planning and strategy with the condition nowadays. Because the Lipitor still beginner.
Starting a new business is not an easy matter, challenges and market competition, also affect the
…show more content…
This strategy is especially suitable for the fast-growing industry that requires huge resources and the prospect of large profits. Companies can also diversified to several other businesses such as Rockwell International (on opening case) who developed the electronics and automotive components …show more content…
When to compete; that is, it requires timing of market entry (for example, being first in the market or waiting until primary demand is established).
The following picture is the key elements of marketing strategy formulation.

Based on the consept of marketing and strategy above, Thus, i can conclude the alternative solutions to solve the problem number 1 of Lipitor. Here, i create two alternative solutions, they are :
1. TheWarner Lambert should merge or work together with Pfizer.
2. Test still secret product against statins already on the market
The Warner Lambert understand that the Merk (main competitor in statin product) has big strength and they know it is on to something big. But to play catch up in the market, it also knew it would need extra marketing muscle. Pfizer then the no.5 drugmaker is known for its sales and marketing prowess and have no statin of its own. The advantages of alternative solution number 1 arethe Lipitor has biger strength, the market reach is larger and the strategies are complete, while the disadvantages are difficult to unit strategies and it is needed to make sure the market once again that there is new merger and adequate to compete the

You May Also Find These Documents Helpful

  • Good Essays

    Biomax Case Summary

    • 1049 Words
    • 5 Pages

    The Company's primary strategy is to get those prescriptions surrendered by other pharmaceutical organizations. Despite the fact that the Company has received 4 standards to screen among the competitors, in any case it confronts the potential danger of disappointment. Drug organizations relinquished these items for a mixture of great reason including security, viability and benefit potential. Why does the Medicines Company have the Golden Finger? There is no such ensure that items which consent to the 4 criteria will end up being a blockbuster product. The Company seems to fail to offer an agreeable advertising arrangement for Angiomax and other future medications that are coming to company regarding to FDA. So we should stay sensible about…

    • 1049 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    The Medicines Company

    • 868 Words
    • 5 Pages

    Medicines Company’s drug, Angiomax, outperforms heparinHeparin, but requireincurs a significantly higher price costs to produce. This , makesing the drug difficult to attractively price towards hospitals. This difficulty in pricing stems from a poor positioning strategy for Angiomax which does not maximize the perceived value (PV) that the drug provides to its key customer segments. Therefore, Medicines Co., must develop a positioning strategy that maximizes the perceived value of Angiomax to a key customer segment.…

    • 868 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    The purpose of this article is to figure out the most efficient way for Loblaw to open up new business in pharmaceutical industry. We believe that acquisition is the best.…

    • 821 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Strategy: Pfizer is the world’s number one pharmaceutical company. Its best-selling products include Lipitor, the world’s best- selling medicine, and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
  • Satisfactory Essays

    Tengion Case Study

    • 262 Words
    • 2 Pages

    Comments: Finding a business opportunity is an art. And Medicines Company thrives upon this unique idea of developing abandoned drugs which still have some remaining value for the market. One such drug is Angiomax which is a blood thinning drug or anticoagulant. Main reasons for selecting Angiomax were its effectiveness over existing drug Heparin, another alternative to the only drug Heparin available for angioplasty and the cost to produce the Angiomax could be reduced to half making it economically viable business. After getting FDA approval, the management board of Medicines Company is facing go to market pricing issues with Angiomax and their inability to come up with a right price for the drug. The main reason for the current pricing problem is already existing widely used competitor drug Heparin, which is priced only at $2/dose. In order to position Angiomax in the market Medicines Company have to analyse its advantages and economic value in comparison to Heparin.…

    • 262 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Hbr Vertex Case Critique

    • 1920 Words
    • 8 Pages

    However, as the industry was entering 21st century, it was also facing couple of challenges: Firstly, companies started to experience a declining productivity in their R&D pipelines. Secondly, there were concerns being raised about the increasing cost of health care in recent years. Lastly, new laws and regulations are being introduced in patent protection and clinical testing areas. As a result of these factors, big Pharmaceutical companies were switching their preferences from entering early stage research partnerships to alliances for drug candidates that have more and promising clinical data.…

    • 1920 Words
    • 8 Pages
    Powerful Essays
  • Good Essays

    Analysis To gain an understanding and find some possible explanations, we will analyze the situation from different points a view. Be big and arrogant Big companies have great advantages like economies of scale, well managed infrastructure, brand equity and substantial market share, but some only try to defend their market share, focusing only on processes and product creation instead of listening to customers (Christensen, 1999). For example, Eli Lilly had almost the 80% of the US insulin market and did not want to introduce new products like the insulin pens because potential cannibalization´s risks (Christensen, 2004). By the other hand, the managers of Pfizer thought they had a product that was going to revolutionize the market. But, after their failure, they blamed the drug´s launching, the marketing campaign and the sales strategy. For them the product was excellent (Simons, 2007), that is, the problem was outside the company.…

    • 1248 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Health Care Reform

    • 1041 Words
    • 5 Pages

    The popular brand name versus the generic battle is a concern in the prescription medicine industry. The uses of brand name drugs have decreased to 20% of total distribution. The expiration of patents of drugs, led to the decrease in brand name distribution. This affects the health care industry in an intense way. This multi-billion dollar industry is affected and patients and physicians must choose whether the generic brand will suffice. Choices by consumer are affected because the cost…

    • 1041 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Angiomax Case

    • 2260 Words
    • 10 Pages

    After 4 years hard working, 30 million dollars in acquiring Angiomax, further R&D, and initiate marketing test, in order to successfully market the first flagship drug Angiomax, the Medicines Company now have a couple of decisions to make in terms of initial pricing, segmentation, marketing strategies, etc (see exhibit 1).…

    • 2260 Words
    • 10 Pages
    Powerful Essays
  • Powerful Essays

    Sanofi-Aventis Acquisition

    • 5913 Words
    • 19 Pages

    With regards to the market share ranking of the pharmaceutical sector by revenues, the leader in 2003 was Pfizer, GlaxoSmithKline, Merck, Johnson & Johnson and Aventis. However, due to patent expirations and new successful drug launches, the ranking of top pharmaceutical companies constantly faces numerous variations. The most sold drug in 2003 was Lipitor manufactured by Pfizer, with a global market share of 2.2%, or equivalently sales worth $10.3 billion. During this time, there were 64 blockbusters (products generating over $ 1 billion in sales).…

    • 5913 Words
    • 19 Pages
    Powerful Essays
  • Better Essays

    Firstly, Johnson & Johnson Pharmaceutical uses focused differentiation technique in marketing its new proprietary medicines (Saylor 5, 2013). In 2013, it came up with three major medicines: INVOKANA (canagliflozin), IMBRUVICA (ibrutinib) and OLYSIO (simeprevir) (Johnson & Johnson [J&J], 2013). Each medicine has its own focused market: INVOKANA for Type 2 diabetic patients, which affects approximately 26 million people in the United States; IMBRUVICA for people with the rare mantle cell lymphoma, and; OLYSIO for those with chronic hepatitis C. Canagliflozin, for instance, is the first medicine in a new class of drug called the oral inhibitors of sodium glucose cotransporter 2 (SGLT2) to reach the market in the United States…

    • 1955 Words
    • 8 Pages
    Better Essays
  • Good Essays

    In contrast with the research findings of Scherer at al., it is that in the pharmaceutical company large number of the diversified portfolio might not return huge profits. The strategy of the Rumack pharmaceuticals was that they expanded their product range to sustain and then capitalize upon the market share, which the product variants would secure for the company. In case of the pharmaceutical industry the rate of growth often demanded by the market to be sustainable for the company, usually would coerce the pharmaceuticals to engage in the low risk activities which was the same as in the case of Rumack.…

    • 830 Words
    • 4 Pages
    Good Essays
  • Good Essays

    Merck Case

    • 587 Words
    • 4 Pages

    Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999, and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research, and (2) developing partnerships with smaller biotechnology companies. Since 1995, Merck had launched 15 new products that earned $5.9 billion on sales of $32.7 billion. Furthermore, Merck may agree to license new drugs from other firms and with its larger capital and greater assets, can assume the risk of submitting the drug through various regulatory approval phases. If the drug becomes profitable, Merck can earn significant cash flows while paying a royalty to the licensor. However, most important is the option that Merck has in deciding when to abandon or continue on this project (deferability or optionality). If Merck reaches a point when its expected NPV is negative, it can simply abandon the project. As a licensee, Merck can allow smaller biotechnology firms to focus on research and development. These smaller firms often have smaller budgets and are not financially or personnel equipped to handle the costly and long FDA approval process, and the subsequent marketing, distribution, and sales of new drugs. This task is better suited for a larger company, such as Merck, which has more resources and money.…

    • 587 Words
    • 4 Pages
    Good Essays
  • Good Essays

    This is a report on a marketing plan of SQUARE Pharmaceuticals Limited, it describes how they can be marketed, and established, increased it shares value against other direct or indirect competitor. It describes the ways, strategies & tactics to make their product well accepted in the market. It discusses about their market situation, competitors position, targeted consumers, organizations objectives, this report also includes actions plans to implement to reach it is desired objectives, financial aspects & how can the organization control & evaluate all the related factors in this marketing plan.…

    • 2123 Words
    • 11 Pages
    Good Essays
  • Satisfactory Essays

    2. How did Zocor neutralize the entry strategy of Vidastat in the anti-cholesterol market? If you were the product manager for Zocor, what might your strategy have been if you had been faced with the same situation?…

    • 327 Words
    • 2 Pages
    Satisfactory Essays